Carrie R Howell1, Lindsay A Thompson2, Heather E Gross3, Bryce B Reeve4, Darren A DeWalt5, I-Chan Huang6. 1. Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN, USA. 2. Department of Pediatrics, College of Medicine, University of Florida, Gainesville, FL, USA. 3. Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. 4. Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. 5. Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. 6. Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN, USA. Electronic address: i-chan.huang@stjude.org.
Abstract
OBJECTIVE: To compare the responsiveness to change of the Patient-Reported Outcomes Measurement Information System (PROMIS(®)) asthma impact, pain interference, fatigue, depressive symptoms, mobility, and peer relationship scales to a legacy scale, the Paediatric Asthma Quality of Life Questionnaire (PAQLQ). METHODS: Two hundred and twenty-nine child-parent dyads from public insurance programs were enrolled. PROMIS pediatric short forms (SFs) and the PAQLQ were used to measure health-related quality of life across four time points (T1-T4) over 2 years. The Asthma Control and Communication Instrument was used to measure the change in asthma control, and the Global Rating of Change (GRC) Index for breathing problems and overall health was used to measure the change in health status. Responsiveness was tested by comparing the changes in health-related quality of life with the changes in asthma control and health status over time using t tests, generalized estimating equations, and relative validity approaches. Magnitudes of the responsiveness between the Pediatric PROMIS and PAQLQ were assessed through statistical significance, Cohen's d effect size (ES), and standardized response mean (SRM). RESULTS: The PROMIS asthma impact scale and all PAQLQ scales exhibited significant responsiveness (p's<0.05) and small to medium ES/SRM when anchored to asthma control, GRC breathing problems, and overall health. Relative validity, especially related to change in asthma control status and GRC breathing problems, was equivalent. PROMIS pain interference, fatigue, and mobility SFs also indicated adequate responsiveness. CONCLUSIONS: The PROMIS asthma impact SF indicated similar responsiveness to the PAQLQ scales. Due to its brevity and responsiveness, the PROMIS asthma impact SF is useful for clinical practice or research.
OBJECTIVE: To compare the responsiveness to change of the Patient-Reported Outcomes Measurement Information System (PROMIS(®)) asthma impact, pain interference, fatigue, depressive symptoms, mobility, and peer relationship scales to a legacy scale, the Paediatric Asthma Quality of Life Questionnaire (PAQLQ). METHODS: Two hundred and twenty-nine child-parent dyads from public insurance programs were enrolled. PROMIS pediatric short forms (SFs) and the PAQLQ were used to measure health-related quality of life across four time points (T1-T4) over 2 years. The Asthma Control and Communication Instrument was used to measure the change in asthma control, and the Global Rating of Change (GRC) Index for breathing problems and overall health was used to measure the change in health status. Responsiveness was tested by comparing the changes in health-related quality of life with the changes in asthma control and health status over time using t tests, generalized estimating equations, and relative validity approaches. Magnitudes of the responsiveness between the Pediatric PROMIS and PAQLQ were assessed through statistical significance, Cohen's d effect size (ES), and standardized response mean (SRM). RESULTS: The PROMIS asthma impact scale and all PAQLQ scales exhibited significant responsiveness (p's<0.05) and small to medium ES/SRM when anchored to asthma control, GRC breathing problems, and overall health. Relative validity, especially related to change in asthma control status and GRC breathing problems, was equivalent. PROMIS pain interference, fatigue, and mobility SFs also indicated adequate responsiveness. CONCLUSIONS: The PROMIS asthma impact SF indicated similar responsiveness to the PAQLQ scales. Due to its brevity and responsiveness, the PROMIS asthma impact SF is useful for clinical practice or research.
Authors: Michael Seid; Christine A Limbers; Kimberly A Driscoll; Lisa A Opipari-Arrigan; Leticia Reyes Gelhard; James W Varni Journal: J Asthma Date: 2010-03 Impact factor: 2.515
Authors: Jin-Shei Lai; Brian D Stucky; David Thissen; James W Varni; Esi Morgan DeWitt; Debra E Irwin; Karin B Yeatts; Darren A DeWalt Journal: Qual Life Res Date: 2013-02-02 Impact factor: 4.147
Authors: Sandra R Wilson; Cynthia S Rand; Michael D Cabana; Michael B Foggs; Jill S Halterman; Lynn Olson; William M Vollmer; Rosalind J Wright; Virginia Taggart Journal: J Allergy Clin Immunol Date: 2012-03 Impact factor: 10.793
Authors: Jordana K Schmier; Ranjani Manjunath; Michael T Halpern; Mechelle L Jones; Katherine Thompson; Gregory B Diette Journal: Ann Allergy Asthma Immunol Date: 2007-03 Impact factor: 6.347
Authors: Karin B Yeatts; Brian Stucky; David Thissen; Deb Irwin; James W Varni; Esi Morgan DeWitt; Jin-Shei Lai; Darren A DeWalt Journal: J Asthma Date: 2010-04 Impact factor: 2.515
Authors: Debra E Irwin; Brian D Stucky; David Thissen; Esi Morgan Dewitt; Jin Shei Lai; Karin Yeatts; James W Varni; Darren A DeWalt Journal: Qual Life Res Date: 2010-03-05 Impact factor: 4.147
Authors: Daphne Koinis-Mitchell; Sheryl J Kopel; Julie Boergers; Kara Ramos; Monique LeBourgeois; Elizabeth L McQuaid; Cynthia A Esteban; Roald Seifer; Gregory K Fritz; Robert Klein Journal: J Clin Sleep Med Date: 2015-01-15 Impact factor: 4.062
Authors: Cecilia M Patino; Sande O Okelo; Cynthia S Rand; Kristin A Riekert; Jerry A Krishnan; Kathy Thompson; Ruth I Quartey; Deanna Perez-Williams; Andrew Bilderback; Barry Merriman; Laura Paulin; Nadia Hansel; Gregory B Diette Journal: J Allergy Clin Immunol Date: 2008-10-11 Impact factor: 10.793
Authors: Kelly M Kenzik; Sanjeev Y Tuli; Dennis A Revicki; Elizabeth A Shenkman; I-Chan Huang Journal: Med Decis Making Date: 2014-04-16 Impact factor: 2.583
Authors: Jerry A Krishnan; Molly A Martin; Cortland Lohff; Giselle S Mosnaim; Helen Margellos-Anast; Julie A DeLisa; Kate McMahon; Kim Erwin; Leslie S Zun; Michael L Berbaum; Michael McDermott; Nina E Bracken; Rajesh Kumar; S Margaret Paik; Sharmilee M Nyenhuis; Stacy Ignoffo; Valerie G Press; Zachary E Pittsenbarger; Trevonne M Thompson Journal: Contemp Clin Trials Date: 2017-03-31 Impact factor: 2.226
Authors: Z Li; W L Leite; L A Thompson; H E Gross; E A Shenkman; B B Reeve; D A DeWalt; I-C Huang Journal: Clin Exp Allergy Date: 2016-10-21 Impact factor: 5.018
Authors: Bryce B Reeve; Lloyd J Edwards; Byron C Jaeger; Pamela S Hinds; Carlton Dampier; Debbie S Gipson; David T Selewski; Jonathan P Troost; David Thissen; Vaughn Barry; Heather E Gross; Darren A DeWalt Journal: Qual Life Res Date: 2017-09-07 Impact factor: 4.147
Authors: Carrie R Howell; Lindsay A Thompson; Heather E Gross; Bryce B Reeve; Shih-Wen Huang; Darren A DeWalt; I-Chan Huang Journal: Ann Allergy Asthma Immunol Date: 2017-11-06 Impact factor: 6.347
Authors: Erica J Brenner; Millie D Long; Courtney M Mann; Wenli Chen; Camila Reyes; Li Lin; Bryce B Reeve; Michael D Kappelman Journal: Inflamm Bowel Dis Date: 2021-02-16 Impact factor: 5.325